Treatment with statins was associated with a significantly decreased risk of diabetic retinopathy in patients with type 2 diabetes and high cholesterol in a large cohort study from Taiwan.
Statin therapy was also associated with a lower need for invasive treatments for vision-threatening diabetic retinopathy, and the benefits of statin treatment were dose dependent.
While several widely reported studies, including ACCORD-EYE, have suggested that statin treatment slows progression of diabetic retinopathy in patients with diabetes and dyslipidemia, the new study, published online in JAMA Ophthalmology, is among the first to assess statin use for the primary prevention of the eye disorder.
Diabetic retinopathy is a leading microvascular complication of diabetes. According to one estimate, as many as 191 million people worldwide will have developed the vision-threatening eye disorder by 2030.